Bioinformatic approaches to investigate mechanisms driving the non-T cell-inflamed tumor microenvironment

被引:0
|
作者
Luke, Jason [1 ]
机构
[1] Univ Chicago Med, Chicago, IL USA
来源
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
K10
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment
    Gajewski, Thomas F.
    Corrales, Leticia
    Williams, Jason
    Horton, Brendan
    Sivan, Ayelet
    Spranger, Stefani
    TUMOR IMMUNE MICROENVIRONMENT IN CANCER PROGRESSION AND CANCER THERAPY, 2017, 1036 : 19 - 31
  • [2] Molecular drivers of the non-T cell-inflamed tumor microenvironment in urothelial bladder cancer
    Sweis, Randy F.
    Spranger, Stefani
    Gajewski, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Molecular correlates of T cell-inflamed and non-T cell-inflamed tumors
    Bao, Riyue
    Luke, Jason J.
    CLINICAL CANCER RESEARCH, 2020, 26 (12) : 23 - 24
  • [4] The Non-T Cell-Inflamed Tumor: A Model for Pancreatic Cancer
    Skowron, K. B.
    Zheng, W.
    Namm, J. P.
    Burnette, B.
    Fu, Y.
    Weichselbaum, R. R.
    Posner, M. C.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S155 - S155
  • [5] Molecular correlates of the non-T cell-inflamed tumor microenvironment in head and neck squamous cell carcinoma
    Bao, Riyue
    Luke, Jason J.
    CLINICAL CANCER RESEARCH, 2020, 26 (12) : 52 - 53
  • [6] The STING pathway and the T cell-inflamed tumor microenvironment
    Woo, Seng-Ryong
    Corrales, Leticia
    Gajewski, Thomas F.
    TRENDS IN IMMUNOLOGY, 2015, 36 (04) : 250 - 256
  • [8] Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types
    Riyue Bao
    Daniel Stapor
    Jason J. Luke
    Genome Medicine, 12
  • [9] Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types
    Bao, Riyue
    Stapor, Daniel
    Luke, Jason J.
    GENOME MEDICINE, 2020, 12 (01)
  • [10] CHARACTERIZATION OF NON-T CELL-INFLAMED BLADDER CANCER TO ENHANCE IMMUNOTHERAPY RESPONSE
    Sweis, R. F.
    Spranger, S.
    Bao, R.
    Paner, G. P.
    Stadler, W. M.
    Steinberg, G. D.
    Gajewski, T. F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S14 - S14